PD-1:PD-1 ligand interactions suppress B-1b cell responses to T cell-independent type 2 antigens

被引：0
|
作者：
Haas, Karen [1 ]
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
来源：
JOURNAL OF IMMUNOLOGY | 2011年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
61.7
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens
    Haas, Karen M.
    Johnson, Kristen L.
    Phipps, James P.
    Do, Cardinal
    JOURNAL OF IMMUNOLOGY, 2018, 200 (05): : 1671 - 1681
  • [2] The PD-1 Regulatory Axis Inhibits T Cell-Independent B Cell Memory Generation and Reactivation
    Spurrier, M. Ariel
    Jennings-Gee, Jamie E.
    Daly, Christina A.
    Haas, Karen M.
    JOURNAL OF IMMUNOLOGY, 2021, 207 (08): : 1978 - 1989
  • [3] PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
    Xu-Monette, Zijun Y.
    Zhou, Jianfeng
    Young, Ken H.
    BLOOD, 2018, 131 (01) : 68 - 83
  • [4] In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
    Reddy, Vishwanatha R. A. P.
    Mwangi, William
    Sadigh, Yashar
    Nair, Venugopal
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [5] Rapamycin Impairs Human Endothelial Cell Alloimmunogenicity Independent of PD-1/PD-1 Ligand Inhibitory Signaling.
    Gao, Q.
    Bendersky, V.
    Kirk, A.
    Xu, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 362 - 362
  • [6] Programmed Cell Death 1 Suppresses B-1b Cell Expansion and Long-Lived IgG Production in Response to T Cell-Independent Type 2 Antigens
    Haas, Karen M.
    JOURNAL OF IMMUNOLOGY, 2011, 187 (10): : 5183 - 5195
  • [7] PD-1 blockade and T cell responses in merkel cell carcinoma
    Miller, N. J.
    Church, C.
    Fling, S.
    Kulikauskas, R.
    Ramchurren, N.
    Shinohara, M.
    Cheever, M.
    Topalian, S. L.
    Nghiem, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S45 - S45
  • [8] PD-1 and impaired antitumor T cell responses in melanoma
    不详
    IMMUNOTHERAPY, 2009, 1 (06) : 924 - 924
  • [9] PD-L2 is a second ligand for PD-1 and inhibits T cell activation
    Yvette Latchman
    Clive R. Wood
    Tatyana Chernova
    Divya Chaudhary
    Madhuri Borde
    Irene Chernova
    Yoshiko Iwai
    Andrew J. Long
    Julia A. Brown
    Raquel Nunes
    Edward A. Greenfield
    Karen Bourque
    Vassiliki A. Boussiotis
    Laura L. Carter
    Beatriz M. Carreno
    Nelly Malenkovich
    Hiroyuki Nishimura
    Taku Okazaki
    Tasuku Honjo
    Arlene H. Sharpe
    Gordon J. Freeman
    Nature Immunology, 2001, 2 : 261 - 268
  • [10] Diagnostic and prognostic utility of PD-1 in B cell lymphomas
    Muenst, S.
    Hoeller, S.
    Willi, N.
    Dirnhofera, S.
    Tzankov, A.
    DISEASE MARKERS, 2010, 29 (01) : 47 - 53
12345